Nash Huw M. Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
30
Insider Sells Sum
$9.04M

Insider Activity of Nash Huw M.

Biography of Nash Huw M.

No biography is available at this moment.

2024-07-02SaleStoke Therapeutics, Inc.
STOK
Chief Business Officer
2,500
0.0049%
$13.11$32,779-9.78%
2024-05-20SaleStoke Therapeutics, Inc.
STOK
COO & CBO
50,000
0.0917%
$15.39$769,500-24.13%
2024-04-01SaleStoke Therapeutics, Inc.
STOK
COO & CBO
61,329
0.1299%
$13.23$811,212-6.82%
2024-03-19SaleStoke Therapeutics, Inc.
STOK
COO & CBO
4,116
0.0097%
$6.10$25,102+117.84%
2022-01-03SaleStoke Therapeutics, Inc.
STOK
COO & CBO
3,800
0.0102%
$23.07$87,666-34.9%
2021-12-01SaleStoke Therapeutics, Inc.
STOK
COO & CBO
5,700
0.0166%
$24.44$139,330-31.03%
2021-11-03SaleStoke Therapeutics, Inc.
STOK
COO & CBO
1,900
0.0049%
$25.00$47,500-34.84%
2021-11-01SaleStoke Therapeutics, Inc.
STOK
COO & CBO
3,800
0.0101%
$23.54$89,456-26.97%
2021-10-01SaleStoke Therapeutics, Inc.
STOK
COO & CBO
5,700
0.0147%
$24.83$141,506-27.93%
2021-09-01SaleStoke Therapeutics, Inc.
STOK
COO & CBO
5,700
0.0152%
$26.00$148,223-26.06%
2021-08-02SaleStoke Therapeutics, Inc.
STOK
COO & CBO
5,700
0.0155%
$28.87$164,554-29.57%
2021-07-01SaleStoke Therapeutics, Inc.
STOK
COO & CBO
5,700
0.0152%
$33.33$189,987-34.04%
2021-06-01SaleStoke Therapeutics, Inc.
STOK
COO & CBO
575
0.0016%
$39.43$22,669-38.54%
2021-01-06SaleStoke Therapeutics, Inc.
STOK
COO & CBO
32
<0.0001%
$57.14$1,828-46.19%
2021-01-04SaleStoke Therapeutics, Inc.
STOK
COO & CBO
5,700
0.0158%
$58.97$336,157-45.34%
2020-12-18SaleStoke Therapeutics, Inc.
STOK
COO & CBO
8,015
0.0239%
$60.00$480,900-45.5%
2020-12-01SaleStoke Therapeutics, Inc.
STOK
COO & CBO
5,700
0.0173%
$49.84$284,080-31.42%
2020-11-10SaleStoke Therapeutics, Inc.
STOK
COO & CBO
50,000
0.1452%
$45.00$2.25M-23.39%
2020-11-02SaleStoke Therapeutics, Inc.
STOK
COO & CBO
5,700
0.0168%
$37.21$212,110-4.52%
2020-10-01SaleStoke Therapeutics, Inc.
STOK
COO & CBO
5,700
0.0172%
$34.54$196,901+11.11%
Total: 30
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.